Vitamin D status and response to anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease

被引：0
|
作者：
Bak, N. F. [1 ]
Hald, S. [1 ]
Rasch, M. B. [1 ]
Dige, A. [2 ]
Agnholt, J. S. [1 ]
Dahlerup, J. F. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, DK-8000 Aarhus, Denmark
[2] Reg Hosp Horsens, Dept Med, Horsens, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P478
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [1] The Impact of Vitamin D on Response to Anti-tumor Necrosis Factor-α Therapy in Children With Inflammatory Bowel Disease
    Hizarcioglu-Gulsen, Hayriye
    Kaplan, Jess L.
    Moran, Christopher J.
    Israel, Esther J.
    Lee, Hang
    Winter, Harland
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (05): : E125 - E131
  • [2] Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children's immunity
    Lee, Ko Eun
    Jung, Sung-Ae
    Park, Sang Hyoung
    Moon, Chang Mo
    Shim, So Yeon
    Kim, Eun Soo
    Cho, Su Jin
    Kim, Seong-Eun
    Cho, Kwang Bum
    Yang, Suk-Kyun
    [J]. INTESTINAL RESEARCH, 2019, 17 (02) : 237 - 243
  • [3] Effectiveness and safety of vedolizumab in pediatric inflammatory bowel disease after failure of anti-tumor necrosis factor-alpha therapy
    Khan, R.
    Thacker, K.
    Spargo, M.
    Dutt, S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 201 - 201
  • [4] Infection and anti-tumor necrosis factor-alpha therapy
    Zandman-Goddard, G
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (11): : 814 - 816
  • [5] Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission
    Scarallo, Luca
    Bolasco, Giulia
    Barp, Jacopo
    Bianconi, Martina
    di Paola, Monica
    Di Toma, Michele
    Naldini, Sara
    Paci, Monica
    Renzo, Sara
    Labriola, Flavio
    De Masi, Salvatore
    Alvisi, Patrizia
    Lionetti, Paolo
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 183 - 191
  • [6] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    [J]. World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [7] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [8] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
  • [9] Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha
    Matar, Manar
    Levi, Rachel
    Zvuloni, Maya
    Shamir, Raanan
    Assa, Amit
    [J]. PEDIATRIC RESEARCH, 2023, 93 (01) : 131 - 136
  • [10] Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha
    Manar Matar
    Rachel Levi
    Maya Zvuloni
    Raanan Shamir
    Amit Assa
    [J]. Pediatric Research, 2023, 93 : 131 - 136
12345